American Axle & Manufacturing v. Neapco Holdings LLC

977 F.3d 1379
Court of Appeals for the Federal Circuit·Decided October 23, 2020·No. 18-1763·Published·Cited by 3 cases

Opinion

Case: 18-1763 Document: 139 Page: 1 Filed: 10/23/2020

United States Court of Appeals for the Federal Circuit ______________________

AMERICAN AXLE & MANUFACTURING, INC., Plaintiff-Appellant

v.

NEAPCO HOLDINGS LLC, NEAPCO DRIVELINES LLC, Defendants-Appellees ______________________

2018-1763 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-01168-LPS, Chief Judge Leonard P. Stark. ______________________

ON MOTION ______________________

JAMES RICHARD NUTTALL, Steptoe & Johnson LLP, Chicago, IL, for plaintiff-appellant. Also represented by JOHN LLOYD ABRAMIC, KATHERINE H. JOHNSON, ROBERT KAPPERS; CHRISTOPHER ALAN SUAREZ, Washington, DC.

J. MICHAEL HUGET, Honigman LLP, Ann Arbor, MI, for defendants-appellees. Also represented by SARAH E. WAIDELICH; DENNIS J. ABDELNOUR, Chicago, IL. ______________________

Before DYK, MOORE, and TARANTO, Circuit Judges. Case: 18-1763 Document: 139 Page: 2 Filed: 10/23/2020

2 AMERICAN AXLE & MANUFACTURING v. NEAPCO HOLDINGS LLC

Order for the court filed by Circuit Judge DYK. Concurring opinion filed by Circuit Judge MOORE. DYK, Circuit Judge. ORDER Plaintiff-appellant American Axle & Manufacturing, Inc. (“AAM”) filed a motion to stay issuance of the mandate pending the filing of a petition for writ of certiorari in the Supreme Court. Defendants-appellees opposed the motion. I Federal Rule of Appellate Procedure 41 provides that a motion for stay of the mandate “must show that the peti- tion would present a substantial question and that there is good cause for a stay.” Fed. R. App. P. 41(d)(1). The Advi- sory Committee Notes state that “[t]he Supreme Court has established conditions that must be met before it will stay a mandate.” Fed. R. App. P. 41, advisory committee’s note to 1994 amendment (citing Robert L. Stern et al., Supreme Court Practice § 17.19 (6th ed. 1986)). In this respect, the Advisory Committee Notes refer to the standard estab- lished by the in-chambers opinions of the individual jus- tices. See Stern et al., supra, § 17.19. The Supreme Court itself has approved this standard in Hollingsworth v. Perry, 558 U.S. 183, 190 (2010). This standard requires that the applicant show “(1) a reasonable probability that four Justices will consider the issue sufficiently meritorious to grant certiorari; (2) a fair prospect that a majority of the Court will vote to reverse the judgment below; and (3) a likelihood that irreparable harm will result from the denial of a stay. In close cases the Circuit Justice or the Court will balance the equities and weigh the relative harms to the applicant and to the respondent.” Id. Chief Justice Roberts, acting as the Circuit Justice for this court, specifically applied that standard in a patent Case: 18-1763 Document: 139 Page: 3 Filed: 10/23/2020

AMERICAN AXLE & MANUFACTURING v. NEAPCO HOLDINGS 3 LLC

case, denying a stay solely for lack of irreparable injury. Teva Pharms. USA, Inc. v. Sandoz, Inc., 572 U.S. 1301, 1301–02 (2014) (Roberts, C.J., in chambers). After we held certain of Teva’s patent claims invalid, Teva sought a stay in order to prevent market entry by the generic pharma- ceutical company respondents. The Chief Justice noted that the first two requirements for a stay were met, be- cause the Supreme Court had already granted certiorari and Teva had “shown a fair prospect of success on the mer- its.” Id. at 1301. But he denied a stay because a likelihood of irreparable injury was not shown, explaining that “[r]espondents acknowledge[d] that, should Teva prevail . . . and its patent be held valid, Teva [would] be able to recover damages from respondents for past patent infringe- ment” and therefore “the extraordinary relief that Teva [sought was] unwarranted.” Id. at 1301–02. As a matter of Federal Circuit law, we interpret the Rule as requiring application of the standard articulated by the Supreme Court in Hollingsworth and the Justices’ in-chambers opinions. See Biodex Corp. v. Loredan Bio- medical, Inc., 946 F.2d 850, 858 (Fed. Cir. 1991) (Federal Circuit law, not regional circuit law, governs such matters). II In this case, AAM has not made the required showing of a likelihood of irreparable injury absent a stay. With respect to claim 22 and related claims, the decision of this court requires no further action by the district court since the claims have been held to be unpatentable. AAM argues that “[i]f the Supreme Court grants review and decides that the asserted claims of [AAM’s patent] are patent eligible under § 101, this Court will have to recall its mandate to conform its disposition with such a decision.” Mot. 14, ECF No. 136. This action, common to every case in which the Supreme Court does not affirm, is not irreparable harm. With respect to claim 1 and related claims, the decision of this court remands to the district court for further Case: 18-1763 Document: 139 Page: 4 Filed: 10/23/2020

4 AMERICAN AXLE & MANUFACTURING v. NEAPCO HOLDINGS LLC

proceedings. AAM argues that there is “good cause for a stay” because it “intends to petition for certiorari with re- gard to the entirety” of our judgment and argues that “[s]ig- nificant burdens and expenses would accrue” should the mandate issue because “the parties and district court would continue to litigate issues related to claim 1.” Id. at 12–13. Continued litigation with respect to claim 1 cannot be irreparable injury. “Mere litigation expense, even sub- stantial and unrecoupable cost, does not constitute irrepa- rable injury.” Renegotiation Bd. v. Bannercraft Clothing Co., 415 U.S. 1, 24 (1974); see also Commonwealth Oil Re- fin. Co. v. Lummus Co., 82 S. Ct. 348, 349 (1961) (Harlan, J., in chambers) (denying motion for stay of the mandate where the only possible harm from denial of the stay was that it could “set in motion the machinery for arbitration and . . . other matters affecting the possible future conduct of the arbitration”); Nara v. Frank, 494 F.3d 1132, 1133 (3d Cir. 2007) (need to “prepar[e] to commence trial within 120 days while simultaneously filing a petition for certiorari” was not irreparable injury under Rule 41); United States v. Microsoft Corp., No. 00-5212, 2001 WL 931170, at *1 (D.C. Cir. Aug. 17, 2001) (denying motion to stay mandate under Rule 41 because movant “failed to demonstrate any sub- stantial harm that would result from the reactivation of proceedings in the district court during the limited pen- dency of the certiorari petition.”). AAM has cited no authority suggesting that the pro- spect of further district court proceedings while the case is on review could constitute irreparable injury. AAM points to the Practice Note to this court’s Rule 41, which reminds litigants that their right to seek certiorari is unaffected by the issuance of the mandate and, “[c]onsequently, a motion to stay the mandate should advance reasons for the stay beyond the mere intention to apply for certiorari, e.g., to forestall action in the trial court or agency that would ne- cessitate a remedial order of the Supreme Court if the writ of certiorari were granted.” Fed. Cir. R. 41 practice note. Case: 18-1763 Document: 139 Page: 5 Filed: 10/23/2020

AMERICAN AXLE & MANUFACTURING v.

Free access — add to your briefcase to read the full text and ask questions with AI

American Axle & Manufacturing v. Neapco Holdings LLC, 977 F.3d 1379 (Fed. Cir. 2020).

977 F.3d 1379 (American Axle & Manufacturing v. Neapco Holdings LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related